Literature DB >> 12641343

Iron metabolism in the reticuloendothelial system.

Mitchell Knutson1, Marianne Wessling-Resnick.   

Abstract

Comprised mainly of monocytes and tissue macrophages, the reticuloendothelial system (RES) plays two major roles in iron metabolism: it recycles iron from senescent red blood cells and it serves as a large storage depot for excess iron. Although iron recycling by the RES represents the largest pathway of iron efflux in the body, the precise mechanisms involved have remained elusive. However, studies characterizing the function and regulation of Nramp1, DMT1, HFE, FPN1, CD163, and hepcidin are rapidly expanding our knowledge of the molecular aspects of RE iron handling. This review summarizes fundamental physiological and biochemical aspects of iron metabolism in the RES and focuses on how recent studies have advanced our understanding of these areas. Also discussed are novel insights into the molecular mechanisms contributing to the abnormal RE iron metabolism characteristic of hereditary hemochromatosis and the anemia of chronic disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641343     DOI: 10.1080/713609210

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  97 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 2.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

Review 3.  Flatiron mice and ferroportin disease.

Authors:  Erin E Johnson; Marianne Wessling-Resnick
Journal:  Nutr Rev       Date:  2007-07       Impact factor: 7.110

Review 4.  Iron transport proteins: Gateways of cellular and systemic iron homeostasis.

Authors:  Mitchell D Knutson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 5.  New strategies to target iron metabolism for the treatment of beta thalassemia.

Authors:  Paraskevi Rea Oikonomidou; Carla Casu; Stefano Rivella
Journal:  Ann N Y Acad Sci       Date:  2016-02-25       Impact factor: 5.691

Review 6.  Hepcidin and its role in iron absorption.

Authors:  K J Robson
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

Review 8.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Iron loading increases ferroportin heterogeneous nuclear RNA and mRNA levels in murine J774 macrophages.

Authors:  Fikret Aydemir; Supak Jenkitkasemwong; Sukru Gulec; Mitchell D Knutson
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

Review 10.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.